Treatment

LY4152199 - IV clinical trials

1 indexed studies · 1 currently recruiting

Not yet recruitingPHASE1
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
This study is testing a new drug, LY4152199, for people with certain types of B-cell lymphoma that have returned or not responded to previous treatments. Researchers want to find the best dose and see how safe and effective it is.
For: Lymphoma, Non-Hodgkin · B-cell Lymphoma · Lymphoma, Large B-Cell, Diffuse
United States · Australia · Canada